Country: United States
Language: English
Source: NLM (National Library of Medicine)
HOMATROPINE HYDROBROMIDE (UNII: BEW7469QZ0) (HOMATROPINE - UNII:8QS6WCL55Z)
Altaire Pharmaceuticals Inc.
OPHTHALMIC
PRESCRIPTION DRUG
A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre and postoperative states when mydriasis is required. Use as an optical aid in some cases of axial lens opacities. Contraindicated in persons with primary glaucoma or a tendency toward glaucoma, e.g. narrow anterior chamber angle, and in those persons showing hypersensitivity to any component of this preparation.
5mL size in a white plastic bottle 5mL - NDC 59390-192-05 Store at 15° - 30°C (59°- 86°F). Caution: Federal (USA) law prohibits dispensing without prescription. Mfd. by: Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 R05/13 F# 16545
unapproved drug other
HOMATROPINE HYDROBROMIDE OPHTHALMIC- HOMATROPINE HYDROBROMIDE SOLUTION ALTAIRE PHARMACEUTICALS INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- HOMATROPINE HYDROBROMIDE OPHTHALMIC SOLUTION, USP HOMATROPINE HYDROBROMIDE OPHTHALMIC SOLUTION, USP RX ONLY ESTABLISHED NAME: Homatropine Hydrobromide CHEMICAL NAME: Benzeneacetic acid, ɑ-hydroxy-, 8-methyl-8-azabicyclo [3.2.1]-oct-3-yl ester, hydrobromide, _endo_-(±)-. The active ingredient is represented by the chemical structure: Each mL contains: Active: Homatropine Hydrobromide 5.0%. Preservative: Benzalkonium Chloride 0.005%. Inactive: Boric Acid, Edetate Disodium, Potassium Chloride, Water for Injection. Boric Acid or Sodium Carbonate may be added to adjust the pH. INDICATIONS AND USAGE: A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre and postoperative states when mydriasis is required. Use as an optical aid in some cases of axial lens opacities. DOSAGE AND ADMINISTRATION: For refraction, instill one or two drops topically in the eye(s). May be repeated in five or ten minutes if necessary. For uveitis, instill one or two drops topically up to every three to four hours. Individuals with heavily pigmented irides may require larger doses. CONTRAINDICATIONS: Contraindicated in persons with primary glaucoma or a tendency toward glaucoma, e.g. narrow anterior chamber angle, and in those persons showing hypersensitivity to any component of this preparation. WARNING: For topical use only – not for injection. Risk-benefit should be considered when the following medical problems exist: keratoconus (Homatropine may produce fixed dilated pupil); Down’s syndrome, children with brain damage and the elderly (increased susceptibility). In infants and small children, use with extreme caution. Excessive use in pediatric Read the complete document